Skip to main content
Livermore
Livermore
ZHEN

Allarity Therapeutics, Inc.

ALLR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001860657

No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Allarity Therapeutics, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of ALLR: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders16114−1
Shares1.29M246.7K950.6K−94.8K (−9.1%)
Value$1.40M$266.4K$1.04M−$92.7K (−8.2%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held Allarity Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to ALLR in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC171,795$187.3K0.00%
Vanguard Fiduciary Trust Co74,913$81.7K0.00%
Citigroup Inc7,766$8.46K0.00%
Jones Financial Companies LLLP1$10.00%
Caitong International Asset Management Co., Ltd1$10.00%

Sold out (6)

Institutions that held Allarity Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of ALLR in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
DRW Securities, LLC122,741$132.6K
Capital Advisors Inc100,000$108.0K
Citadel Advisors LLC84,591$91.4K
Private Advisor Group, LLC55,536$60.0K
HRT Financial LP10,347$11.0K
Bank of America Corp140$151

Not filed for Q1 2026 yet (1)

Institutions that held Allarity Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ALLR in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc246,708$266.4K